Abstract:SUMOylation, which is a type of post-translational modification that involves covalent conjugation of small ubiquitin-like modifier (SUMO) proteins to target substrates, regulates various important molecular and cellular processes, including transcription, the cell cycle, cell signaling, and DNA synthesis and repair. Newly synthesized SUMO is immature and cleaved by the SUMO-specific protease family, resulting in exposure of the C-terminal Gly–Gly motif to become the mature form. In the presence of ATP, mature SUMO is conjugated with the activating enzyme E1 through the cysteine residue of E1, followed by transfer to the cysteine residue of E2-conjugating enzyme Ubc9 in humans that recognizes and modifies the lysine residue of a substrate protein. E3 SUMO ligases promote SUMOylation. SUMOylation is a reversible modification and mediated by SUMO-specific proteases. Cumulative studies have indicated that SUMOylation affects the functions of protein substrates in various manners, including cellular localization and protein stability. Gene knockout studies in mice have revealed that several SUMO cycling machinery proteins are crucial for the development and differentiation of various cell lineages, including immune cells. Aberrant SUMOylation has been implicated in several types of diseases, including cancers, cardiovascular diseases, and autoimmune diseases. This review summarizes the biochemistry of SUMO modification and the general biological functions of proteins involved in SUMOylation. In particular, this review focuses on the molecular mechanisms by which SUMOylation regulates the development, maturation, and functions of immune cells, including T, B, dendritic, and myeloid cells. This review also discusses the underlying relevance of disruption of SUMO cycling and site-specific interruption of SUMOylation on target proteins in immune cells in diseases, including cancers and infectious diseases.

Roles of host SUMOylation in bacterial pathogenesis

The crosstalk between SUMOylation and immune system in host-pathogen interactions

Modulation of Host Ubiquitination Pathways by Pathogenic Bacterial Effector Proteins

Diversity Of Bacterial Manipulation Of The Host Ubiquitin Pathways

SUMOylation at the crossroads of gut health: insights into physiology and pathology

Mechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells

Exploitation of the host cell ubiquitin machinery by microbial effector proteins

SUMOylation in Viral Replication and Antiviral Defense

Speaking the host language: how Salmonella effector proteins manipulate the host

Role of SUMOylation in Human Oncogenic Herpesvirus Infection

Salmonella secretion systems: Differential roles in pathogen-host interactions

Contributions of Mass Spectrometry-Based Proteomics to Understanding Salmonella-Host Interactions

The emerging roles of SUMOylation in pulmonary diseases

The Critical Roles of the SUMO-Specific Protease SENP3 in Human Diseases and Clinical Implications

dampens SUMOylation and promotes intestinal inflammation

Time-Resolved Multiomics Illustrates Host and Gut Microbe Interactions during Salmonella Infection

Role of Protein Glycosylation in Host-Pathogen Interaction

Insights into the regulatory role of bacterial sncRNA and its extracellular delivery via OMVs

The Emerging Roles of SUMOylation in the Tumor Microenvironment and Therapeutic Implications

Molecular basis of host specificity in human pathogenic bacteria

Subversion of Macrophage Functions by Bacterial Protein Toxins and Effectors